Diabetes Devices Market Size To Reach $101.66 Billion By 2033

May 2026 | Report Format: Electronic (PDF)

Diabetes Devices Market Growth & Trends

The global diabetes devices market size is estimated to reach USD 101.66 billion by 2033, registering a CAGR of 10.5% from 2026 to 2033, according to a new report by Grand View Research, Inc. The market is primarily driven by factors such as the increasing incidence of diabetes, coupled with technological advancements and innovative product launches.

Rising adoption of advanced diabetes management solutions in developing regions, government policies, and rising medical tourism are some of the major factors contributing to the market growth. Furthermore, the rising government initiative to spread diabetes awareness and increasing R&D expenditure of major market players are the factors expected to ensure long-term market growth. According to the NCBI report, global health expenditure on diabetes is expected to reach USD 490 billion in 2030 from 376 billion in 2010.

Obesity, sedentary lifestyle, and fast food culture are some of the factors having a significant impact on the market growth. According to Harvard T.H. Chan School of Public Health, the U.S has the highest rates of obesity with every third person being obese and this rate is expected to reach 50% by 2030.

In addition, an increasing number of new market players are transforming the market. New market entrants focus on patient convenience with the help of artificial intelligence technology. They are leveraging technological advancements to improve diabetes care solutions like CGM devices non-invasive insulin delivery systems and digital diabetes management platforms. For Instance, In December 2017, Companion Medical Launched Inpen, its first smart insulin pen system in the U.S. It is the only FDA-approved solution that can combine insulin injector pens with a smart app.

key Request a free sample copy or view report summary: Diabetes Devices Market Report

Diabetes Devices Market Report Highlights

Based on type, the BGM devices segment dominated the market in 2025 and accounted for the largest share of 57.8%, driven by the increasing global prevalence of diabetes, rising demand for self-monitoring solutions, and growing adoption of home-based diabetes management technologies.
Based on distribution channel, the hospital pharmacies segment dominated the market and held the largest revenue share in 2025.
Based on end-use, the hospitals segment dominated the industry and held the largest revenue share in 2025, attributed to the increasing number of diabetes-related hospitalizations, rising prevalence of uncontrolled diabetes and associated complications, and growing adoption of advanced diabetes management technologies in inpatient care settings.
North America diabetes devices market and accounted for the largest revenue share of 44.2% in 2025, driven by the high prevalence of diabetes, strong adoption of advanced diabetes management technologies, favorable reimbursement frameworks, and well-established healthcare infrastructure across the region.

Diabetes Devices Market Segmentation

Grand View Research has segmented the global diabetes devices market based on type, distribution channel, end-use, and region:

Diabetes Devices Type Outlook (Revenue, USD Million, 2021 - 2033)

BGM Devices
- Self-Monitoring Devices
  - Blood Glucose Meters
  - Testing Strips
  - Lancets
- Continuous Glucose Monitoring Devices
  - Sensors
  - Transmitters
  - Receiver
Insulin Delivery Devices
- Pumps
- Pens
- Syringes
- Jet Injectors